| Literature DB >> 32118082 |
Luke Donovan1, Scott Hetzel2, Craig R Laufenberg3, Timothy A McGuine4.
Abstract
BACKGROUND: The prevalence and impact of chronic ankle instability (CAI) in adolescent athletes are unknown. To better develop and justify prevention strategies of lateral ankle sprains and CAI, it is important to understand the origin and associated long-term impact of CAI within populations other than adults. PURPOSE/HYPOTHESIS: The purpose of this study was to determine the prevalence and impact of CAI on ankle function, health-related quality of life (HRQoL), and physical activity in adolescent athletes. The hypothesis was that the presence of CAI will be commonly reported among adolescent athletes and that participants with CAI will have lower self-reported ankle function, HRQoL, and physical activity when compared with participants without CAI. STUDYEntities:
Keywords: disablement; functional ankle instability; health-related quality of life; lateral ankle sprain
Year: 2020 PMID: 32118082 PMCID: PMC7029541 DOI: 10.1177/2325967119900962
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Participant Demographics
| Female (n = 505) | Male (n = 497) | |
|---|---|---|
| Age, mean ± SD, y | 15.7 ± 1.7 | 15.6 ± 1.9 |
| Distribution of age, n (%) | ||
| 14 y | 101 (20.0) | 108 (21.7) |
| 15 y | 126 (25.0) | 138 (27.8) |
| 16 y | 137 (27.1) | 104 (20.9) |
| 17 y | 124 (24.6) | 130 (26.2) |
| 18 y | 17 (3.4) | 17 (3.4) |
| Sport participation, n (%) | ||
| Basketball | 302 (59.8) | 253 (50.9) |
| Football | 1 (0.2) | 385 (77.5) |
| Volleyball | 345 (68.3) | 21 (4.2) |
| Baseball/softball | 103 (20.4) | 133 (26.8) |
| Track | 89 (17.6) | 99 (19.9) |
| Soccer | 100 (19.8) | 49 (9.9) |
| Cross-country | 29 (5.7) | 7 (1.4) |
| Tennis | 16 (3.2) | 12 (2.4) |
| Golf | 9 (1.8) | 12 (2.4) |
| Wrestling | 0 (0.0) | 19 (3.8) |
| Lacrosse | 0 (0.0) | 17 (3.4) |
| Ice hockey | 3 (0.6) | 13 (2.6) |
| Other | 8 (1.6) | 12 (2.4) |
| Ankle function scores | ||
| FAAM-ADL | 100.0 (98.8-100.0) | 100.0 (98.8-100.0) |
| FAAM-Sport | 100.0 (96.9-100.0) | 100.0 (96.9-100.0) |
| HRQoL scores | ||
| PedsQL emotional | 100.0 (85.0-100.0) | 100.0 (90.0-100.0) |
| PedsQL social | 100.0 (95.0-100.0) | 100.0 (95.0-100.0) |
| PedsQL school | 95.0 (80.0-100.0) | 100.0 (80.0-100.0) |
| PedsQL physical | 100.0 (90.6-100.0) | 100.0 (93.8-100.0) |
| PedsQL psychosocial | 96.7 (86.7-100.0) | 96.7 (88.3-100.0) |
| Total PedsQL | 95.6 (88.0-100.0) | 95.7 (88.0-100.0) |
| Physical activity scores | ||
| HSS Pedi-FABS | 24.0 (19.0-27.0) | 26.0 (22.0-28.0) |
Data are reported as median (interquartile range) unless otherwise indicated. ADL, Activities of Daily Living; FAAM, Foot and Ankle Ability Measure; HRQoL, health-related quality of life; HSS Pedi-FABS, Hospital for Special Surgery Pediatric Functional Activity Brief Scale; PedsQL, Pediatric Quality of Life Inventory 4.0.
History of Ankle Sprains and Prevalence of CAI
| Female (n = 505) | Male (n = 497) | |
|---|---|---|
| Ankle sprain history | ||
| Previous ankle sprain, n (%) | 147 (29.1) | 115 (23.1) |
| No. of ankle sprains per participant | 0.0 (0.0-1.0) | 0.0 (0.0-0.0) |
| IdFAI score | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) |
| CAI prevalence, n (%) | ||
| No CAI | 386 (76.4) | 416 (83.7) |
| Unilateral CAI | 98 (19.4) | 65 (13.1) |
| Bilateral CAI | 21 (4.1) | 16 (3.2) |
CAI, chronic ankle instability; IdFAI, Identification of Functional Ankle Instability.
Data are reported as median (interquartile range) and include participants both with and without a previous ankle sprain within the analysis.
Distribution of Ankle Function, HRQoL, and Physical Activity for Participants With and Without Chronic Ankle Instability
| n | Mean ± SD | 95% CI | Range | IQR | Median | ||
|---|---|---|---|---|---|---|---|
| Ankle function | |||||||
| FAAM-ADL | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 98.5 ± 4.4 | 98.2-98.8 | 51.8-100.0 | 99.4-100.0 | 100.0 | |
| Unilateral | 163 | 91.8 ± 11.5 | 90.0-93.5 | 29.8-100.0 | 88.1-100.0 | 96.4 | |
| Bilateral | 37 | 85.5 ± 15.9 | 80.2-90.8 | 42.9-100.0 | 81.5-97.6 | 91.1 | |
| Male | <.001 | ||||||
| None | 416 | 98.5 ± 4.3 | 98.1-98.9 | 57.1-100.0 | 99.4-100.0 | 100.0 | |
| Unilateral | 65 | 89.0 ± 14.7 | 85.3-92.6 | 29.8-100.0 | 81.5-100.0 | 93.5 | |
| Bilateral | 16 | 86.8 ± 14.4 | 79.1-94.5 | 54.8-100.0 | 81.7-97.2 | 91.4 | |
| Female | <.001 | ||||||
| None | 386 | 98.5 ± 4.6 | 98.1-99.0 | 51.8-100.0 | 99.4-100.0 | 100.0 | |
| Unilateral | 98 | 93.6 ± 8.4 | 91.9-95.3 | 64.9-100.0 | 91.8-99.9 | 97.0 | |
| Bilateral | 21 | 84.5 ± 17.2 | 76.7-92.3 | 42.9-99.4 | 81.5-97.6 | 89.3 | |
| FAAM-Sport | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 97.7 ± 6.0 | 97.2-98.1 | 31.2-100.0 | 98.4-100.0 | 100.0 | |
| Unilateral | 163 | 87.0 ± 14.8 | 84.7-89.2 | 15.6-100.0 | 78.1-98.4 | 93.8 | |
| Bilateral | 37 | 77.5 ± 21.4 | 70.4-84.6 | 20.3-100.0 | 75.0-89.1 | 84.4 | |
| Male | <.001 | ||||||
| None | 416 | 97.8 ± 5.6 | 97.2-98.3 | 54.7-100.0 | 98.4-100.0 | 100.0 | |
| Unilateral | 65 | 83.5 ± 17.7 | 79.1-87.8 | 15.6-100.0 | 75.0-98.4 | 89.1 | |
| Bilateral | 16 | 80.4 ± 19.4 | 70.0-90.7 | 39.1-100.0 | 80.9-92.6 | 85.9 | |
| Female | <.001 | ||||||
| None | 386 | 97.6 ± 6.5 | 96.9-98.2 | 31.2-100.0 | 98.4-100.0 | 100.0 | |
| Unilateral | 98 | 89.3 ± 12.1 | 86.8-91.7 | 45.3-100.0 | 82.4-98.4 | 95.3 | |
| Bilateral | 21 | 75.3 ± 23.0 | 64.8-85.8 | 20.3-96.9 | 75.0-89.1 | 82.8 | |
| HRQoL | |||||||
| Total PedsQL | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 93.5 ± 9.1 | 92.8-94.1 | 44.6-100.0 | 90.2-100.0 | 97.5 | |
| Unilateral | 163 | 89.8 ± 9.8 | 88.3-91.4 | 41.9-100.0 | 85.3-97.5 | 91.9 | |
| Bilateral | 37 | 86.4 ± 10.3 | 83.0-89.9 | 64.5-100.0 | 79.5-94.2 | 89.7 | |
| Male | <.001 | ||||||
| None | 416 | 94.0 ± 8.4 | 93.2-94.8 | 57.8-100.0 | 92.1-100.0 | 97.8 | |
| Unilateral | 65 | 89.7 ± 9.6 | 87.3-92.1 | 56.9-100.0 | 84.7-96.1 | 91.3 | |
| Bilateral | 16 | 89.1 ± 10.9 | 83.3-94.9 | 64.5-100.0 | 85.0-96.2 | 93.5 | |
| Female | <.001 | ||||||
| None | 386 | 92.9 ± 9.8 | 91.9-93.9 | 44.6-100.0 | 89.1-100.0 | 96.7 | |
| Unilateral | 98 | 89.9 ± 10.1 | 87.9-92.0 | 41.9-100.0 | 85.6-97.9 | 92.4 | |
| Bilateral | 21 | 84.4 ± 9.5 | 80.1-88.7 | 64.7-98.9 | 77.2-90.5 | 85.9 | |
| PedsQL emotional | |||||||
| All athletes | .001 | ||||||
| None | 802 | 92.7 ± 13.8 | 91.7-93.6 | 20.0-100.0 | 90.0-100.0 | 100.0 | |
| Unilateral | 163 | 89.1 ± 16.4 | 86.6-91.7 | 20.0-100.0 | 82.5-100.0 | 95.0 | |
| Bilateral | 37 | 86.5 ± 14.1 | 81.8-91.2 | 50.0-100.0 | 80.0-100.0 | 90.0 | |
| Male | .005 | ||||||
| None | 416 | 94.1 ± 11.6 | 93.0-95.2 | 30.0-100.0 | 95.0-100.0 | 100.0 | |
| Unilateral | 65 | 90.2 ± 13.5 | 86.9-93.6 | 40.0-100.0 | 85.0-100.0 | 95.0 | |
| Bilateral | 16 | 91.9 ± 11.8 | 85.6-98.2 | 60.0-100.0 | 85.0-100.0 | 97.5 | |
| Female | <.001 | ||||||
| None | 386 | 91.2 ± 15.7 | 89.6-92.8 | 20.0-100.0 | 90.0-100.0 | 100.0 | |
| Unilateral | 98 | 88.4 ± 18.2 | 84.8-92.1 | 20.0-100.0 | 81.2-100.0 | 100.0 | |
| Bilateral | 21 | 82.4 ± 14.6 | 75.7-89.0 | 50.0-100.0 | 75.0-95.0 | 80.0 | |
| HRQoL (continued) | |||||||
| PedsQL social | |||||||
| All athletes | .824 | ||||||
| None | 802 | 95.2 ± 9.6 | 94.5-95.9 | 25.0-100.0 | 95.0-100.0 | 100.0 | |
| Unilateral | 163 | 95.8 ± 8.5 | 94.5-97.1 | 55.0-100.0 | 95.0-100.0 | 100.0 | |
| Bilateral | 37 | 95.9 ± 7.2 | 93.5-98.4 | 75.0-100.0 | 95.0-100.0 | 100.0 | |
| Male | .906 | ||||||
| None | 416 | 95.0 ± 10.0 | 94.1-96.0 | 25.0-100.0 | 95.0-100.0 | 100.0 | |
| Unilateral | 65 | 95.0 ± 9.4 | 92.7-97.3 | 55.0-100.0 | 95.0-100.0 | 100.0 | |
| Bilateral | 16 | 95.6 ± 6.3 | 92.3-99.0 | 85.0-100.0 | 90.0-100.0 | 100.0 | |
| Female | .643 | ||||||
| None | 386 | 95.4 ± 9.1 | 94.5-96.3 | 40.0-100.0 | 95.0-100.0 | 100.0 | |
| Unilateral | 98 | 96.3 ± 7.9 | 94.7-97.9 | 60.0-100.0 | 96.2-100.0 | 100.0 | |
| Bilateral | 21 | 96.2 ± 8.0 | 92.5-99.9 | 75.0-100.0 | 100.0-100.0 | 100.0 | |
| PedsQL school | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 89.8 ± 14.8 | 88.7-90.8 | 20.0-100.0 | 85.0-100.0 | 100.0 | |
| Unilateral | 163 | 85.8 ± 17.3 | 83.1-88.5 | 15.0-100.0 | 80.0-100.0 | 90.0 | |
| Bilateral | 37 | 84.5 ± 15.4 | 79.3-89.6 | 50.0-100.0 | 75.0-100.0 | 85.0 | |
| Male | .096 | ||||||
| None | 416 | 89.7 ± 14.4 | 88.3-91.1 | 30.0-100.0 | 80.0-100.0 | 100.0 | |
| Unilateral | 65 | 87.0 ± 15.0 | 83.3-90.7 | 40.0-100.0 | 80.0-100.0 | 90.0 | |
| Bilateral | 16 | 85.0 ± 15.2 | 76.9-93.1 | 50.0-100.0 | 78.8-100.0 | 85.0 | |
| Female | .004 | ||||||
| None | 386 | 89.9 ± 15.2 | 88.3-91.4 | 20.0-100.0 | 85.0-100.0 | 100.0 | |
| Unilateral | 98 | 85.0 ± 18.7 | 81.2-88.8 | 15.0-100.0 | 76.2-100.0 | 90.0 | |
| Bilateral | 21 | 84.0 ± 16.0 | 76.8-91.3 | 50.0-100.0 | 75.0-100.0 | 85.0 | |
| PedsQL physical | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 95.5 ± 8.7 | 94.9-96.1 | 28.1-100.0 | 93.8-100.0 | 100.0 | |
| Unilateral | 163 | 88.9 ± 12.1 | 87.0-90.8 | 46.9-100.0 | 84.4-100.0 | 93.8 | |
| Bilateral | 37 | 81.3 ± 18.6 | 75.1-87.5 | 28.1-100.0 | 68.8-93.8 | 90.6 | |
| Male | <.001 | ||||||
| None | 416 | 96.2 ± 7.9 | 95.4-97.0 | 50.0-100.0 | 96.9-100.0 | 100.0 | |
| Unilateral | 65 | 87.2 ± 12.9 | 84.0-90.4 | 53.1-100.0 | 81.2-100.0 | 87.5 | |
| Bilateral | 16 | 84.6 ± 19.0 | 74.4-94.7 | 28.1-100.0 | 86.7-96.9 | 90.6 | |
| Female | <.001 | ||||||
| None | 386 | 94.7 ± 9.4 | 93.8-95.6 | 28.1-100.0 | 93.8-100.0 | 100.0 | |
| Unilateral | 98 | 90.0 ± 11.5 | 87.7-92.3 | 46.9-100.0 | 87.5-100.0 | 93.8 | |
| Bilateral | 21 | 78.9 ± 18.4 | 70.5-87.2 | 50.0-96.9 | 59.4-93.8 | 90.6 | |
| PedsQL psychosocial | |||||||
| All athletes | <.001 | ||||||
| None | 802 | 92.5 ± 10.6 | 91.8-93.3 | 38.3-100.0 | 88.3-100.0 | 96.7 | |
| Unilateral | 163 | 90.2 ± 11.2 | 88.5-92.0 | 35.0-100.0 | 85.0-100.0 | 93.3 | |
| Bilateral | 37 | 89.0 ± 9.7 | 85.7-92.2 | 63.3-100.0 | 83.3-98.3 | 91.7 | |
| Male | .202 | ||||||
| None | 416 | 92.9 ± 9.9 | 92.0-93.9 | 48.3-100.0 | 90.0-100.0 | 96.7 | |
| Unilateral | 65 | 90.7 ± 10.3 | 88.2-93.3 | 46.7-100.0 | 86.7-100.0 | 93.3 | |
| Bilateral | 16 | 90.8 ± 9.0 | 86.0-95.6 | 71.7-100.0 | 85.8-98.3 | 93.3 | |
| Female | .003 | ||||||
| None | 386 | 92.1 ± 11.3 | 91.0-93.3 | 38.3-100.0 | 88.3-100.0 | 96.7 | |
| Unilateral | 98 | 89.9 ± 11.9 | 87.5-92.3 | 35.0-100.0 | 85.0-100.0 | 93.3 | |
| Bilateral | 21 | 87.5 ± 10.2 | 82.9-92.2 | 63.3-100.0 | 83.3-93.3 | 90.0 | |
| Physical activity | |||||||
| HSS Pedi-FABS | |||||||
| All athletes | .664 | ||||||
| None | 802 | 23.3 ± 5.1 | 23.0-23.7 | 4.0-30.0 | 20.0-28.0 | 25.0 | |
| Unilateral | 163 | 22.8 ± 6.2 | 21.8-23.7 | 2.0-30.0 | 20.0-28.0 | 25.0 | |
| Bilateral | 37 | 22.5 ± 6.0 | 20.5-24.5 | 6.0-30.0 | 22.0-26.0 | 25.0 | |
| Male | .344 | ||||||
| None | 416 | 23.8 ± 5.3 | 23.2-24.3 | 6.0-30.0 | 21.0-28.0 | 25.0 | |
| Unilateral | 65 | 24.2 ± 6.0 | 22.7-25.7 | 2.0-30.0 | 22.0-28.0 | 26.0 | |
| Bilateral | 16 | 23.3 ± 4.9 | 20.7-25.9 | 10.0-30.0 | 22.8-26.0 | 24.5 | |
| Female | .55 | ||||||
| None | 386 | 22.9 ± 4.9 | 22.4-23.4 | 4.0-30.0 | 19.0-27.0 | 24.0 | |
| Unilateral | 98 | 21.8 ± 6.1 | 20.6-23.1 | 5.0-29.0 | 18.2-27.0 | 23.0 | |
| Bilateral | 21 | 21.9 ± 6.7 | 18.9-25.0 | 6.0-30.0 | 17.0-27.0 | 25.0 | |
ADL, Activities of Daily Living; FAAM, Foot and Ankle Ability Measure; HRQoL, health-related quality of life; HSS Pedi-FABS, Hospital for Special Surgery Pediatric Functional Activity Brief Scale; IQR, interquartile range; PedsQL, Pediatric Quality of Life Inventory 4.0.
values are from the Kruskal-Wallis test.
Significant post hoc Wilcoxon rank-sum test results after the Holm adjustment: none versus unilateral, none versus bilateral, and unilateral versus bilateral.